Harmony Biosciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $186,038 | $172,814 | $154,615 | $168,412 |
Gross Profit | 143,260 | 134,709 | 121,170 | 125,260 |
EBITDA | 72,486 | 27,408 | 58,157 | 46,321 |
EBIT | 66,518 | 21,356 | 52,033 | 40,196 |
Net Income | 46,093 | 11,591 | 38,334 | 26,607 |
Net Change In Cash | 186,038 | 172,814 | 154,615 | 168,412 |
Free Cash Flow | 70,498 | 41,985 | 31,136 | 76,558 |
Cash | 387,367 | 317,296 | 332,981 | 311,660 |
Basic Shares | 58,103 | 57,541 | 57,597 | 58,853 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $582,022 | $437,855 | $305,440 | $159,742 |
Gross Profit | 460,786 | 354,374 | 249,922 | 132,004 |
EBITDA | 216,389 | 143,571 | 106,368 | 1,513 |
EBIT | 192,030 | 120,186 | 87,528 | -8,724 |
Net Income | 128,853 | 181,468 | 34,597 | -51,856 |
Net Change In Cash | 582,022 | 437,855 | 305,440 | 159,742 |
Cost of Revenue | 9,475 | 5,678 | 204,174 | |
Free Cash Flow | 219,075 | 104,294 | -1,741 | -4,987 |
Cash | 311,660 | 243,784 | 234,309 | 228,631 |
Basic Shares | 60,372 | 61,097 | 59,205 | 56,890 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.79 |
2024-06-30 | $0.20 |
2024-03-31 | $0.67 |
2023-12-31 | $0.45 |
